Hereditary cerebellar ataxia
MONDO:0100310Cerebellar ataxia that is transmitted from parent to child.
Also known as: cerebellar hereditary ataxia, hereditary cerebellar ataxia
133 clinical trials for this condition and its sub-types, 0 tagged with Hereditary cerebellar ataxia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hereditary cerebellar ataxia
-
Autosomal recessive cerebellar ataxia 0 trials · 72 incl. sub-types
29 sub-types
- Autosomal recessive degenerative and progressive cerebellar ataxia 0 trials · 49 incl. sub-types Sub-types →
- Autosomal recessive metabolic cerebellar ataxia 0 trials · 10 incl. sub-types Sub-types →
- Autosomal recessive congenital cerebellar ataxia 0 trials · 7 incl. sub-types Sub-types →
- Autosomal recessive syndromic cerebellar ataxia 0 trials · 2 incl. sub-types Sub-types →
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 0 trials · 2 incl. sub-types Sub-types →
- Charlevoix-Saguenay spastic ataxia 1 trial
- Autosomal recessive spinocerebellar ataxia 7 1 trial
- Lichtenstein-Knorr syndrome 0 trials
- RIDDLE syndrome 0 trials
- Ataxia with oculomotor apraxia type 3 0 trials
- Autosomal recessive ataxia due to ubiquinone deficiency 0 trials
- Autosomal recessive ataxia, Beauce type 0 trials
- Autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome 0 trials Sub-types →
- Autosomal recessive spinocerebellar ataxia 10 0 trials
- Autosomal recessive spinocerebellar ataxia 14 0 trials
- Autosomal recessive spinocerebellar ataxia 16 0 trials
- Autosomal recessive spinocerebellar ataxia 20 0 trials
- Infantile-onset autosomal recessive nonprogressive cerebellar ataxia 0 trials
- Spinocerebellar ataxia, autosomal recessive 22 0 trials
- Spinocerebellar ataxia, autosomal recessive 24 0 trials
- Spinocerebellar ataxia, autosomal recessive 25 0 trials
- Spinocerebellar ataxia, autosomal recessive 26 0 trials
- Spinocerebellar ataxia, autosomal recessive 27 0 trials
- Spinocerebellar ataxia, autosomal recessive 28 0 trials
- Spinocerebellar ataxia, autosomal recessive 29 0 trials
- Spinocerebellar ataxia, autosomal recessive 30 0 trials
- Spinocerebellar ataxia, autosomal recessive 31 0 trials
- Spinocerebellar ataxia, autosomal recessive 32 0 trials
- Spinocerebellar ataxia, autosomal recessive 33 0 trials
-
Autosomal dominant cerebellar ataxia 11 trials · 33 incl. sub-types
15 sub-types
- Autosomal dominant cerebellar ataxia type I 0 trials · 16 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia type III 0 trials · 9 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia type IV 0 trials · 8 incl. sub-types Sub-types →
- Spinocerebellar ataxia 7 7 trials
- Spinocerebellar ataxia 27B, late-onset 4 trials
- Spinocerebellar ataxia 9 2 trials
- Spinocerebellar ataxia 27A 1 trial
- GRID2-related autosomal dominant spinocerebellar ataxia 0 trials
- Spinocerebellar ataxia 43 0 trials
- Spinocerebellar ataxia 44 0 trials
- Spinocerebellar ataxia 47 0 trials
- Spinocerebellar ataxia 48 0 trials
- Spinocerebellar ataxia 49 0 trials
- Spinocerebellar ataxia 50 0 trials
- Spinocerebellar ataxia 51 0 trials
-
Ataxia telangiectasia 11 trials
1 sub-type
-
X-linked cerebellar ataxia 0 trials
9 sub-types
- X-linked intellectual disability-ataxia-apraxia syndrome 0 trials
- X-linked non progressive cerebellar ataxia 0 trials
- X-linked progressive cerebellar ataxia 0 trials
- X-linked sideroblastic anemia with ataxia 0 trials
- X-linked spinocerebellar ataxia type 3 0 trials
- X-linked spinocerebellar ataxia type 4 0 trials
- Ataxia - deafness - intellectual disability syndrome 0 trials
- Fragile X-associated tremor/ataxia syndrome 0 trials
- Spinocerebellar ataxia, X-linked 2 0 trials
-
Ataxia-pancytopenia syndrome 0 trials
Most studied deeper sub-types
-
Experimental Friedreich's ataxia drug tested in kids – but trial halted early
Disease control Stopped earlyThis early-stage trial tested a drug called nomlabofusp (CTI-1601) in 18 adolescents and children with Friedreich's ataxia, a rare genetic disease that affects movement and coordination. The goal was to check safety and how the body processes the drug. However, the study was term…
Phase 1 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Continued EryDex treatment studied in rare neurological disorder
Disease control Stopped earlyThis study offered continued treatment with EryDex to 101 people with ataxia telangiectasia (A-T) who had finished a previous trial. The main goal was to monitor safety, including side effects and serious events. The study was terminated early, and it did not aim to cure the dise…
Phase 3 • Sponsor: Quince Therapeutics S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental drug shows promise for rare genetic disorder
Disease control Stopped earlyThis Phase II trial tested a drug called N-Acetyl-L-Leucine (IB1001) in 17 people with Ataxia-Telangiectasia, a rare genetic disease that affects movement and immunity. The study aimed to see if the drug could improve symptoms and slow the disease over time. The trial was termina…
Phase 2 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virus therapy fails to advance in colorectal cancer trial
Disease control Stopped earlyThis study tested a new approach using a virus that attacks cancer cells (oncolytic immunotherapy) along with two standard drugs (atezolizumab and bevacizumab) in people with advanced colorectal cancer that had stopped responding to other treatments. The trial was stopped early a…
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC